Business
Merck drug less effective against moderate COVID -India regulatory source – Reuters
Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy” against moderate COVID-19,…
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) – Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy”…
Continue Reading
-
Noosa News11 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News20 hours agoStore-bought bee hotels doing more harm than good for native species
-
Noosa News14 hours ago‘They’re not taking the concerns of women seriously’
-
Business15 hours agoDividends from ASX 200 bank shares ‘looking very stretched’: expert